Literature DB >> 34147201

Iliac Vein Stenosis: Is the Data Strong Enough for Stenting in the Young Pelvic Venous Disorders (PeVD) Population?

Oleksandra Kutsenko1, Yuko McColgan2, Gloria Salazar3.   

Abstract

Iliac vein stenosis is a clinical condition resulting from external compression of the iliocaval venous unit with the consequent remodeling of the vascular wall, hemodynamic alterations, and predisposition to venous thrombosis. As such, the most common indications for percutaneous endovascular iliac vein stenting supported by the literature, include the management of thrombotic and non-thrombotic iliac venous lesions associated with advanced chronic venous disease (CVD). However, its clinical presentation is variable, and it may also include features associated with PeVD such as chronic pelvic pain, perineal heaviness, urinary urgency, postcoital pain, and vulvar or superficial non-saphenous veins varicosities. In this setting, the management revolves around the relieving venous obstruction and restoring normal blood flow through the compressed vein with percutaneous endovascular iliac vein stenting, that can be augmented with ovarian vein embolization (OVE) or direct embolization of the superficial varices. Given the heterogeneity of PeVD presentation and the lack of high-level quality data in outcomes for iliac vein stenosis stenting, this review will discuss the current evidence available for this intervention and clinical issues to consider when evaluating these patients.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Iliac Vein Compression; May-Thurner Syndrome; Pelvic Venous Disease; Venous Stenting

Mesh:

Year:  2021        PMID: 34147201     DOI: 10.1016/j.tvir.2021.100733

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  1 in total

1.  Diosmin Alleviates Venous Injury and Muscle Damage in a Mouse Model of Iliac Vein Stenosis.

Authors:  Zhiye Guo; Xiaolong Du; Yihua Zhang; Chunwan Su; Feng Ran; Qiulun Lu
Journal:  Front Cardiovasc Med       Date:  2022-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.